GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, FABP3, GSK3B, HSD17B2, IDO1, IGF1R, MAOB, MMP2, MMP9, NR1H4, NR3C1, PPARA, PTGS2, RORC, SRC, TYR |
9.54016 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, F3, FABP3, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
9.16717 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, FLT3, GSK3B, HCAR2, KDR, MET, MMP12, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, XDH |
9.16717 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, FLT3, GSK3B, HCAR2, KDR, MET, MMP12, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, XDH |
9.16717 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DRD1, F3, FABP3, FABP4, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
9.13344 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, APP, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, FABP3, FABP4, FLT3, GSK3B, HSD17B2, IDO1, IGF1R, KDR, MAOB, MMP2, NR1H4, NR3C1, PPARA, PTGS2, RORC, SRC, TYR |
9.13344 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, FABP3, FUT7, IDO1, NR1H4, PDE5A, PIM1, PPARA, PTGS2, TYR, XDH |
9.00547 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, APP, AR, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DHFR, DRD1, F3, FABP3, FABP4, FLT3, GSK3B, HCAR2, HSD17B1, HSD17B2, KDR, MAOB, MET, NR1H4, PPARA, PTGS2, SRC, THRA, THRB, XDH |
8.89628 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TYR, XDH |
8.19546 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, NR1H4, PPARA, PTGS2 |
7.93066 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, SRC, THRA, THRB |
7.87567 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, APP, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, FABP3, FABP4, FLT3, GSK3B, HSD17B2, IDO1, IGF1R, KDR, MAOB, MMP2, MMP9, NR1H4, NR3C1, PPARA, PTGS2, RORC, SRC, TYR |
7.87567 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, GSK3B, HSD17B1, HSD17B2, IDO1, MAOB, PTGS2, TYR, XDH |
7.55589 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, CDC25B, CSNK2A1, CYP1B1, F3, FABP3, FLT3, IDO1, IGF1R, KDR, MMP12, MMP2, MMP9, PDE5A, PGR, PIM1, PTGS2, SRC, XDH |
7.17435 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, IDO1, MAOB, NR1H4, NR3C1, PTGS2, RORC, SRC, TYR |
7.17435 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, SRC, THRA, XDH |
7.17435 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SRC, THRA, XDH |
7.01039 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, AR, CA2, CSNK2A1, CYP1A2, DRD1, FABP3, FLT3, GSK3B, IGF1R, MAOB, MMP2, NR1H4, NR3C1, PPARA, PTGS2, SRC |
6.96334 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, SRC, THRA, THRB |
6.96334 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TYR, XDH |
6.82527 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, NR1H4, NR3C1, PGR, PIM1, PPARA, RORC, SRC, THRA, THRB |
6.82527 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, GSK3B, HCAR2, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, SRC, THRA |
6.67892 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, HSD17B2, NR1H4 |
6.64614 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ADRA2C, APP, AR, AURKB, CDC25B, CSNK2A1, DHFR, DRD1, F3, FABP3, FLT3, GSK3B, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR1H4, NR3C1, PDE5A, PGR, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
6.50477 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DAO, DHFR, DRD1, MAOB, NR1H4, TYR |
6.47737 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KDR, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SRC, THRA, XDH |
6.44244 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GSK3B, IDO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, SRC |
6.44244 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, F3, FLT3, GSK3B, KDR, MET, MMP12, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, XDH |
6.41676 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, FABP3, FABP4, FUT7, GSK3B, IDO1, MAOB, MMP1, MMP12, MMP2, MMP9, PDE5A, SRC, XDH |
6.41676 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ADRA2C, APP, AR, AURKB, CDC25B, CSNK2A1, DRD1, F3, FLT3, GSK3B, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR1H4, NR3C1, PDE5A, PGR, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
6.41244 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APP, AR, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, FLT3, MAOB, NR3C1, PTGS2, RORC, SRC, TYR |
6.41244 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GSK3B, IDO1, IGF1R, KDR, MET, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SRC |
6.22165 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DRD1, FABP3, FABP4, GSK3B, HCAR2, IDO1, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR1H4, NR3C1, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
6.22165 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DRD1, FABP3, FABP4, GSK3B, IDO1, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR1H4, NR3C1, PDE5A, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
6.16845 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, HCAR2, NR1H4, PPARA, PTGS2, RORC, SRC, THRA |
6.15714 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, DHFR |
6.1553 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX5, APP, AR, AXL, CYP19A1, CYP1A2, CYP1B1, DRD1, F3, FABP4, HSD17B2, IDO1, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTGS2, RORC, SRC, THRA, THRB, TYR |
6.10367 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ADRA2C, APP, AR, AURKB, CDC25B, DRD1, F3, FABP3, FLT3, GSK3B, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR1H4, NR3C1, PDE5A, PGR, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
6.09247 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MAOB, MMP9, PTGS2, SRC |
6.06818 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, THRA, THRB |
6.06818 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, MMP9, NR1H4, NR3C1, PTGS2, RORC, SRC |
5.89042 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, F3, FABP4, FLT3, GSK3B, IDO1, KDR, MET, MMP12, MMP2, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, XDH |
5.79855 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, APP, AR, AXL, CYP1A1, CYP1B1, DRD1, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, NR1H4, NR3C1, PTGS2, RORC, SRC |
5.76265 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TYR, XDH |
5.7623 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, FLT3, GSK3B, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, THRA, XDH |
5.74057 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.69582 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TYR, XDH |
5.69582 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HCAR2, HSD17B1, HSD17B2, NR1H4 |
5.63971 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, FLT3, GSK3B, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, THRA, XDH |
5.63971 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, APP, AR, AXL, CYP1B1, F3, FLT3, KDR, MET, PDE5A, PTGS2, PTPN1, SRC, XDH |
5.61407 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GSK3B, IDO1, IGF1R, KDR, MMP9, NR1H4, PIM1, PTGS2, PTPN1, SRC |
5.59135 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, IDO1, MAOB |
5.50506 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ADRA2C, APP, AR, AURKB, CDC25B, CSNK2A1, DRD1, F3, FLT3, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, NR3C1, PDE5A, PGR, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
5.49611 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, DRD1, GSK3B, IGF1R, MMP2, MMP9, NR1H4, NR3C1, PTGS2, RORC, SRC |
5.47394 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
5.39937 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, THRA, THRB |
5.2921 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, IGF1R, KDR, MET, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, XDH |
5.24545 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, APP, AR, AURKB, AXL, CA2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, FABP4, FLT3, FUT7, GSK3B, HSD17B2, KDR, MAOB, MET, MMP2, MMP9, PGR, PIM1, PPARA, PTGS2, RORC, SRC, THRA, THRB, TYR |
5.1653 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, F3, FABP3, FABP4, FLT3, GSK3B, HSD17B2, IDO1, IGF1R, KDR, MAOB, MMP12, MMP2, MMP9, NR1H4, NR3C1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, TYR |
5.04224 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, APP, AR, CDC25B, DRD1, FABP3, FLT3, KDR, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, XDH |
4.9573 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, APP, AR, CDC25B, DRD1, FABP3, FLT3, KDR, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, XDH |
4.9573 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 |
4.86234 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, APP, CYP19A1, DHFR, F3, FABP4, GSK3B, IDO1, IGF1R, MET, MMP12, MMP2, NR1H4, PPARA, PTGS2, PTPN1, SRC, XDH |
4.66297 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, FABP4, GSK3B, IGF1R, MET, MMP9, NR1H4, PIM1, PPARA, PTGS2, PTPN1, SRC |
4.61409 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DHFR, DRD1, FABP3, FLT3, GSK3B, IGF1R, MMP2, NR1H4, PPARA, PTGS2, SRC, TYR |
4.61409 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DHFR, DRD1, F3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, MET, MMP12, MMP2, MMP9, NR1H4, PDE5A, PPARA, PTGS2, PTPN1, SRC, THRA, XDH |
4.5907 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
4.54049 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 |
4.49958 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, AR, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, MAOB, NR3C1, PPARA, PTGS2, SRC |
4.48984 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, APP, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, FLT3, GSK3B, HSD17B2, KDR, MAOB, MMP9, PGR, PIM1, PPARA, PTGS2, RORC, SRC, THRA, TYR |
4.47628 |
[BP] GO:0022414 |
reproductive process
|
ADRA2C, AKR1B1, APP, AR, AXL, CDC25B, CYP19A1, CYP1A1, DRD1, HSD17B2, IDO1, MMP2, MMP9, PGR, PTGS2, SRC, THRA, THRB |
4.45872 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, ADRA2C, APP, AXL, CA2, CA7, CYP19A1, DRD1, GSK3B, HCAR2, MAOB, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, SRC, THRA |
4.45614 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APP, AR, CYP1A1, CYP1B1, DRD1, FLT3, NR3C1, PTGS2, RORC, SRC |
4.44329 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, ADRA2C, APP, AR, AXL, CA2, CYP1B1, F3, HCAR2, IDO1, KDR, MET, MMP12, MMP9, NR1H4, PDE5A, PIM1, PTGS2, SRC |
4.39463 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, MMP9, NR1H4, NR3C1, PTGS2, PTPN1, RORC, SRC |
4.3923 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, PIM1, SRC |
4.35634 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, AR, DRD1, FLT3, GSK3B, IGF1R, MMP2, NR1H4, NR3C1, PTGS2, SRC |
4.35634 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, APP, CA2, GSK3B, HCAR2, MMP12, NR1H4, PTGS2, PTPN1, SRC, THRA |
4.33173 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DHFR, DRD1, FABP3, FLT3, GSK3B, IGF1R, MMP2, NR1H4, PPARA, PTGS2, SRC, TYR |
4.27789 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, APP, AR, CDC25B, DRD1, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, NR1H4, PDE5A, PPARA, PTGS2, PTPN1, SRC, XDH |
4.2775 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
4.27337 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, MET, PPARA, PTGS2 |
4.23789 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, APP, AR, CDC25B, DRD1, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, NR1H4, PDE5A, PPARA, PTGS2, PTPN1, SRC, XDH |
4.23623 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, DRD1, HCAR2, KDR, NR1H4, PTGS2, SRC |
4.23623 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APP, AR, AURKB, CSNK2A1, DHFR, FABP4, GSK3B, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, NR3C1, PGR, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
4.16046 |
[BP] GO:0007617 |
None
|
APP, DRD1, THRA, THRB |
4.15535 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DAO, DHFR, DRD1, F3, FLT3, FUT7, GSK3B, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, SRC, TYR, XDH |
4.14051 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, FABP3, IDO1, NR1H4, PIM1, PPARA, PTGS2, TYR |
4.08071 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, APP, AR, FLT3, KDR, PDE5A, PTPN1, SRC, XDH |
3.94911 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AR, CDC25B, CSNK2A1, F3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2 |
3.93683 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA, THRA |
3.91997 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
3.91997 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.91997 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, F3, FABP3, FABP4, FLT3, GSK3B, HCAR2, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
3.91311 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, APP, AR, CDC25B, DRD1, FABP4, FLT3, IGF1R, KDR, MMP9, PDE5A, PPARA, PTGS2, PTPN1, SRC, XDH |
3.91311 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.91311 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DHFR, DRD1, F3, FABP3, FABP4, FLT3, GSK3B, HCAR2, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
3.86984 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
3.8608 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, FABP3, HSD17B2, KDR, MMP2, NR1H4, PTGS2, SRC |
3.8535 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, APP, AR, AXL, CA1, CA2, CSNK2A1, CYP1B1, DRD1, F3, FLT3, GSK3B, HCAR2, IGF1R, KDR, MET, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTPN1, RORC, SRC, THRA, THRB |
3.83866 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AXL, CA2, CYP1B1, F3, GSK3B, HCAR2, IDO1, KDR, MET, MMP12, MMP9, NR1H4, PDE5A, PIM1, PTGS2, SRC, THRA, THRB, XDH |
3.80817 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.79722 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.79722 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
3.78308 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, APP, AR, CDC25B, DRD1, FABP4, FLT3, IGF1R, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
3.77587 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, FABP3, FABP4, FUT7, GSK3B, IDO1, MAOB, PDE5A, XDH |
3.74992 |
[BP] GO:0045932 |
None
|
ADORA1, ADRA2C, PDE5A, PTGS2 |
3.7417 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CYP1A1, DRD1, PGR, PTGS2, SRC, THRA, THRB |
3.71775 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AURKB, CDC25B, CSNK2A1, DHFR, DRD1, F3, FABP4, FLT3, GSK3B, IGF1R, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
3.71209 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.69688 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, APP, AR, CDC25B, FLT3, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
3.67796 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DHFR, DRD1, F3, FABP4, FLT3, GSK3B, IGF1R, MET, MMP9, NR1H4, PDE5A, PIM1, PPARA, PTGS2, PTPN1, SRC, XDH |
3.67542 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, FABP3, IDO1, NR1H4, PIM1, PPARA, PTGS2, TYR |
3.67316 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2 |
3.65396 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CYP19A1, DRD1, GSK3B, HCAR2, MMP12, NR1H4, PTGS2, SRC |
3.60186 |
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.59708 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, DAO, DHFR, FABP3, IDO1, NR1H4, PIM1, PPARA, PTGS2, TYR |
3.59708 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.58462 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DAO, DRD1, MAOB |
3.57586 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, AR, DRD1, GSK3B, IGF1R, MET, MMP12, MMP9, NR1H4, PTGS2, PTPN1, SRC, XDH |
3.54439 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, AR, DRD1, GSK3B, IGF1R, MET, MMP12, MMP9, NR1H4, PTGS2, PTPN1, SRC, XDH |
3.52962 |
[BP] GO:0019098 |
None
|
APP, DRD1, THRA, THRB |
3.52517 |
[BP] GO:0007176 |
None
|
ADORA1, ADRA2A, ADRA2C, APP |
3.52517 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.50012 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.50012 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, APP, AR, CDC25B, FLT3, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
3.50012 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, PTGS2 |
3.48024 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, APP, AR, FLT3, IGF1R, KDR, PDE5A, PTPN1, SRC, XDH |
3.47213 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, NR1H4, PPARA, PTGS2, SRC |
3.4489 |
[BP] GO:0032787 |
None
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, IDO1, NR1H4, PPARA, PTGS2 |
3.4489 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
AXL, CYP1A1, CYP1A2, IDO1, MAOB, NR1H4, PTGS2, SRC |
3.43821 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KDR, NR3C1, PTGS2, SRC |
3.38477 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, DRD1, F3, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
3.38477 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CYP1A1, CYP1B1, DHFR, DRD1, FABP3, KDR, MAOB, NR3C1, PTGS2, SRC |
3.37969 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, PDE5A, PTGS2, THRA, THRB |
3.35699 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, ADRA2C, APP, AR, CSNK2A1, GSK3B, HCAR2, MMP12, NR1H4, PTGS2, PTPN1, SRC, THRA |
3.33367 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, ADRA2A, ADRA2C, APP, GSK3B, MAOB, MMP9, NR1H4, PTGS2, THRA |
3.33227 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.33219 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, PPARA, SRC, THRA, TYR |
3.32379 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PDE5A, PTGS2, PTPN1, SRC, THRA, XDH |
3.32379 |
[BP] GO:0061097 |
None
|
ADORA1, ADRA2A, ADRA2C, APP, PTPN1 |
3.31769 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DHFR, DRD1, F3, FABP3, FABP4, FLT3, GSK3B, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
3.31769 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SRC |
3.30144 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, GSK3B, IGF1R, MMP2, NR1H4, PTGS2, SRC |
3.26936 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HCAR2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TYR, XDH |
3.26756 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, FABP3, FABP4, GSK3B, IDO1, MAOB, PDE5A, SRC, XDH |
3.26756 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS2 |
3.26756 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
AXL, CYP1A1, CYP1A2, IDO1, MAOB, NR1H4, PTGS2, SRC |
3.26756 |
[BP] GO:0018958 |
None
|
AKR1B1, DAO, DRD1, MAOB, TYR |
3.22425 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DHFR, DRD1, F3, FABP3, FABP4, FLT3, GSK3B, IGF1R, KDR, MAOB, MET, MMP12, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
3.16992 |
[BP] GO:0045742 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
3.16992 |
[BP] GO:0051223 |
None
|
ACHE, ADRA2A, ADRA2C, APP, GSK3B, HCAR2, MMP12, NR1H4, PTGS2, PTPN1, SRC, THRA |
3.15349 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, F3, FABP4, IDO1, KDR, MET, MMP12, NR1H4, PPARA, PTGS2 |
3.15015 |
[BP] GO:0048545 |
response to steroid hormone
|
AR, CA2, FLT3, MAOB, NR3C1, PTGS2, SRC |
3.14333 |
[BP] GO:0045741 |
None
|
ADORA1, ADRA2A, ADRA2C |
3.11595 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, NR1H4, PPARA |
3.10559 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
3.10559 |
[BP] GO:1901186 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
3.0947 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, APP, AURKB, AXL, CDC25B, CSNK2A1, DHFR, DRD1, FLT3, GSK3B, IGF1R, KDR, MET, PDE5A, PIM1, PTGS2, PTPN1, SRC, XDH |
3.09296 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, HCAR2, NR1H4, PTGS2 |
3.06951 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, FABP4, MAOB, MMP9, PTGS2 |
3.06573 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ADRA2C, APP, AR, AXL, CA2, CYP1B1, F3, IDO1, KDR, NR1H4, PDE5A, PIM1, PTGS2, SRC, THRA |
3.05504 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, ADRA2C, APP, MMP9 |
3.05123 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, GSK3B, IGF1R, MMP2, NR1H4, PTGS2, SRC |
3.0406 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.02707 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, ADRA2C, APP, FLT3, PTPN1, SRC |
3.02042 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, APP, AR, CDC25B, CSNK2A1, F3, FLT3, GSK3B, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
3.01604 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, DRD1, FABP3, IGF1R, KDR, MET, MMP12, NR1H4, NR3C1, PGR, PPARA, PTGS2, RORC, SRC, THRA, THRB |
2.99556 |
[BP] GO:0008050 |
None
|
THRA, THRB |
2.9742 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
2.97223 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, PTGS2, SRC |
2.97223 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, ADRA2C, APP, GSK3B, HCAR2, MMP12, NR1H4, PTGS2, PTPN1, SRC, THRA |
2.96995 |
[BP] GO:0006584 |
None
|
AKR1B1, DAO, DRD1, MAOB |
2.96064 |
[BP] GO:0009712 |
None
|
AKR1B1, DAO, DRD1, MAOB |
2.96064 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, NR1H4, SRC |
2.96064 |
[BP] GO:0061098 |
None
|
ADORA1, ADRA2A, ADRA2C, PTPN1 |
2.96064 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, APP, AR, AXL, CBR1, CDC25B, CYP1A1, DRD1, FABP4, FLT3, FUT7, GSK3B, KDR, MET, MMP2, MMP9, PGR, PTGS2, RORC, SRC, THRA, THRB |
2.90964 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, AR, CYP19A1, DRD1, GSK3B, IGF1R, MET, MMP12, MMP9, NR1H4, PPARA, PTGS2, PTPN1, SRC, XDH |
2.88105 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, DAO, DHFR, TYR |
2.88105 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, CYP19A1, CYP1A2, IDO1, MAOB, XDH |
2.88105 |
[BP] GO:1901361 |
None
|
CYP19A1, CYP1A1, CYP1A2, CYP3A4, DAO, IDO1, MAOB, PDE5A, XDH |
2.87195 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APP, AR, AURKB, CSNK2A1, DHFR, FABP4, GSK3B, IGF1R, MET, MMP12, MMP9, NR1H4, NR3C1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
2.87195 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, F3, FLT3, FUT7, GSK3B, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TYR, XDH |
2.8595 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DHFR, DRD1, F3, FABP4, FLT3, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
2.8595 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, APP, AURKB, AXL, CDC25B, CSNK2A1, DHFR, DRD1, FLT3, GSK3B, IGF1R, KDR, MET, PDE5A, PIM1, PTGS2, PTPN1, SRC, XDH |
2.8595 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, MMP2, PPARA, PTGS2, SRC, THRA, TYR |
2.84742 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GSK3B, IGF1R, PPARA, PTGS2, SRC |
2.83768 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AR, AURKB, CSNK2A1, DHFR, FABP4, GSK3B, IGF1R, KDR, MMP12, MMP9, NR1H4, NR3C1, PGR, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
2.80713 |
[BP] GO:1901184 |
None
|
ADORA1, ADRA2A, ADRA2C, APP, MMP9 |
2.80705 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, ADRA2C, APP, AURKB, CDC25B, FABP4, FLT3, GSK3B, IGF1R, PDE5A, PTPN1, SRC |
2.80042 |
[BP] GO:0045986 |
None
|
ADORA1, ADRA2C, PTGS2 |
2.79222 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, PTGS2 |
2.79149 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, APP, AR, CDC25B, F3, FLT3, GSK3B, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
2.7508 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, ADRA2C, FLT3, PTPN1, SRC |
2.74975 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APP, AXL, CA12, CA2, CA7, DRD1, FABP3, FABP4, FLT3, MET, NR1H4, SRC |
2.73868 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CSNK2A1, MAOB, NR3C1, SRC |
2.6835 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, ADRA2C, APP, AR, CDC25B, FLT3, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
2.67571 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.66202 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, ADRA2C, APP, AR, AURKB, CDC25B, DHFR, F3, FLT3, GSK3B, MET, MMP9, PDE5A, PTPN1, SRC, XDH |
2.66022 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.64792 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.59226 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.59039 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, ADRA2C, APP, AR, CDC25B, DRD1, FABP4, FLT3, IGF1R, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
2.5882 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, DRD1, F3, FABP3, FABP4, FLT3, GSK3B, HCAR2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
2.57959 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.57959 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.57959 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, DRD1, FABP3, IGF1R, MET, MMP12, NR1H4, NR3C1, PGR, PPARA, PTGS2, RORC, SRC, THRA, THRB |
2.5704 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.56532 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP3A4, DAO, MAOB |
2.55746 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, RORC |
2.55746 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, GSK3B, PGR, PPARA, RORC, SRC |
2.53896 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, FABP4, IDO1, MMP12, MMP2, NR1H4, PPARA, PTGS2, PTPN1, SRC |
2.5025 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, APP, CDC25B, FABP4, FLT3, IGF1R, PDE5A, PTPN1, SRC |
2.49416 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, HCAR2, PDE5A, PTGS2, THRA, THRB |
2.48671 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.47787 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.47787 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CYP1A1, CYP1B1, DRD1, KDR, MAOB, SRC |
2.46659 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.42175 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, PTGS2 |
2.4056 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, PTGS2 |
2.4056 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, PTGS2 |
2.40355 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, PTGS2 |
2.40355 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, PTGS2, SRC |
2.39953 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.39693 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.39693 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SRC, XDH |
2.39254 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2 |
2.38357 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, PTGS2 |
2.38114 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.38114 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.38114 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, KDR, SRC |
2.37704 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.3621 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA2A, ADRA2C, PTGS2 |
2.3621 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.36075 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, NR1H4, PPARA |
2.36075 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, APP, AR, CDC25B, CSNK2A1, DHFR, DRD1, F3, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP9, PDE5A, PTGS2, PTPN1, SRC, XDH |
2.35716 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.35508 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, ADRA2C, CYP19A1, HCAR2, MAOB, MMP12, NR1H4, SRC |
2.35372 |
[BP] GO:0035625 |
None
|
ADRA2A, ADRA2C |
2.34813 |
[BP] GO:0032811 |
None
|
ADRA2A, ADRA2C |
2.34813 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.34813 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.34813 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
2.33346 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD17B1, HSD17B2, PTGS2 |
2.33002 |
[BP] GO:0051172 |
None
|
ADRA2A, APP, AR, AURKB, CSNK2A1, DHFR, FABP4, IGF1R, MMP12, MMP9, NR1H4, NR3C1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
2.32866 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, PTGS2 |
2.32065 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, PTGS2 |
2.30653 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, IDO1 |
2.28843 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, ADRA2C, APP, CDC25B, FABP4, FLT3, IGF1R, PDE5A, PTPN1, SRC |
2.27405 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, CYP1B1, FABP3, IDO1, PDE5A, PTGS2, XDH |
2.26762 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, CYP3A4, DHFR, IDO1, PTGS2 |
2.25792 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.25749 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, DRD1, IGF1R, MET, MMP12, NR1H4, NR3C1, PGR, PPARA, PTPN1, RORC, SRC, THRA, THRB |
2.25166 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, NR1H4, SRC |
2.22598 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.21308 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.20815 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, MAOB, MMP9, PTGS2 |
2.2062 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, APP, AR, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, HSD17B1, HSD17B2, IDO1, MAOB, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PPARA, PTGS2, RORC, THRA, THRB, TYR, XDH |
2.20385 |
[BP] GO:0071383 |
None
|
AR, FLT3, NR3C1, SRC |
2.18921 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, HCAR2, MMP12, NR1H4, SRC |
2.18666 |
[BP] GO:0042417 |
None
|
DAO, DRD1, MAOB |
2.17444 |
[BP] GO:0006091 |
generation of precursor metabolites and energy
|
AKR1B1, CYP19A1, CYP1A2, GSK3B, IDO1, MAOB, XDH |
2.17336 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, FLT3, GSK3B, IGF1R, KDR, MET, NR1H4, SRC |
2.16938 |
[BP] GO:0035624 |
None
|
ADRA2A, ADRA2C |
2.16938 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.16938 |
[BP] GO:0060509 |
None
|
THRA, THRB |
2.16938 |
[BP] GO:0014060 |
None
|
ADRA2A, ADRA2C |
2.16938 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1 |
2.15891 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2 |
2.15891 |
[BP] GO:0060341 |
regulation of cellular localization
|
ADRA2A, APP, AR, CSNK2A1, DRD1, GSK3B, NR1H4, PTGS2, PTPN1, SRC, THRA |
2.15701 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, IGF1R, PDE5A, PTPN1, SRC |
2.15484 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, GSK3B, IDO1, MMP2, MMP9, NR1H4, PPARA, PTGS2, PTPN1, SRC, THRA |
2.14992 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, CYP19A1, HCAR2, MAOB, MMP12, NR1H4, SRC |
2.14992 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, PTGS2, SRC, XDH |
2.14703 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, MMP9, PTGS2, SRC |
2.13772 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SRC |
2.13772 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.13516 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, NR3C1, PGR, SRC |
2.12679 |
[BP] GO:0010629 |
None
|
APP, AR, AURKB, DHFR, FABP4, KDR, MMP12, NR1H4, NR3C1, PGR, PPARA, RORC, SRC, THRA, THRB, XDH |
2.12067 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, MAOB |
2.11238 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.11238 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.1117 |
[BP] GO:0070542 |
None
|
FABP3, NR1H4, PTGS2, SRC |
2.09301 |
[BP] GO:0045833 |
None
|
ADORA1, ADRA2A, HCAR2, NR1H4 |
2.09301 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
CYP1B1, F3, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SRC, XDH |
2.08054 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, APP, CA2, CA7, DRD1, MAOB, MMP9, PTGS2 |
2.07836 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, NR3C1, SRC |
2.07836 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07836 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, ADRA2C, APP, AURKB, CDC25B, DHFR, F3, FLT3, GSK3B, PDE5A, PTPN1, SRC, XDH |
2.07672 |
[BP] GO:2000106 |
regulation of leukocyte apoptotic process
|
AURKB, AXL, HCAR2, IDO1 |
2.06123 |
[BP] GO:0031960 |
response to corticosteroid
|
FLT3, MAOB, NR3C1, PTGS2, SRC |
2.06123 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, FLT3, NR1H4, NR3C1, RORC, SRC |
2.06061 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
CYP1B1, F3, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SRC, XDH |
2.05967 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, GSK3B, HCAR2, MMP12, NR1H4, PTGS2, SRC |
2.04961 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.04961 |
[BP] GO:2000273 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.04961 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, IDO1, PTGS2 |
2.04961 |
[BP] GO:0045924 |
None
|
THRA, THRB |
2.04355 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.04355 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.04355 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRA2C, APP, AR, AXL, CA2, CYP1B1, F3, GSK3B, IDO1, KDR, NR1H4, PDE5A, PIM1, PPARA, PTGS2, RORC, SRC, THRA, XDH |
2.02362 |
[BP] GO:0006775 |
fat-soluble vitamin metabolic process
|
CBR1, CYP1A1, CYP3A4 |
2.0203 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DHFR, DRD1, MAOB, PTGS2 |
2.00968 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, HCAR2, MMP12, NR1H4, SRC |
2.00968 |
[BP] GO:0006937 |
None
|
ADORA1, ADRA2A, ADRA2C, PDE5A, PTGS2 |
2.00704 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.00545 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, APP, AR, AURKB, AXL, CA1, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DRD1, F3, FABP3, FABP4, FLT3, GSK3B, HCAR2, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
2.00259 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA2C, AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, CA1, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, IDO1, KDR, MAOB, MMP2, MMP9, NR3C1, NR3C2, PDE5A, PGR, PIM1, PTGS2, PTPN1, SRC, THRA, TYR, XDH |
2.7729 |
[CC] GO:0005829 |
cytosol
|
AKR1B1, AKR1B10, ALOX5, APP, AR, AURKB, CA1, CA2, CA7, CBR1, CDC25B, CSNK2A1, DAO, DHFR, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IDO1, NR3C1, NR3C2, PDE5A, PGR, PIM1, PTPN1, SRC, THRA, TYR, XDH |
2.21308 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.04355 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP |
1.83555 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX5, APP, AR, AXL, CA12, CA14, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DRD1, F3, FLT3, FUT7, GSK3B, HCAR2, HSD17B2, IGF1R, KDR, MAOB, MET, MMP2, NR3C2, PGR, PIM1, PTGS2, PTPN1, SRC, TYR |
1.72667 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, AR, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PGR, PIM1, PPARA, PTPN1, RORC, THRA, THRB, TYR, XDH |
15.4026 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, F3, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, TYR, XDH |
11.4751 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, THRA, THRB |
9.16717 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.15545 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PGR, PPARA, PTPN1, RORC, THRA, THRB |
8.14912 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, HSD17B1, HSD17B2, IDO1, MAOB, PTGS2, TYR, XDH |
7.94522 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, F3, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PTGS2, PTPN1, SRC, TYR, XDH |
7.81957 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, NR1H4, PGR, PPARA, RORC, THRA, THRB |
6.82746 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, NR1H4, PGR, PPARA, RORC, THRA, THRB |
6.82746 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, HSD17B1, NR1H4, NR3C1, NR3C2, PGR, RORC |
6.67892 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, IDO1, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, THRA, THRB, TYR, XDH |
6.44244 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AR, AXL, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, THRA, THRB |
6.41244 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, HSD17B1, IDO1, MAOB, PTGS2, SRC, XDH |
5.85529 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AR, AXL, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, THRA, THRB |
5.62967 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, IDO1, PTGS2, SRC |
5.60167 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, IDO1, MMP1, MMP12, MMP2, MMP9, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, THRA, THRB, TYR, XDH |
5.59135 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.52603 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, NR3C1, THRA, THRB |
5.50506 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AR, AXL, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, THRA, THRB |
5.45053 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, IDO1, PTGS2, SRC |
5.40031 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.2921 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.21952 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AR, AXL, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC, THRA, THRB |
4.99737 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.4749 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, CYP3A4, F3, FABP3, FABP4, HSD17B1, NR1H4, NR3C1, NR3C2, PGR, PPARA, RORC |
4.39463 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.19842 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.94911 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS2, TYR |
3.9309 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, ADRA2C, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, DRD1, FLT3, GSK3B, HSD17B1, IDO1, IGF1R, KDR, MAOB, MET, MMP12, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
3.92284 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
3.86984 |
[MF] GO:0004887 |
None
|
NR1H4, THRA, THRB |
3.75731 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DHFR, DRD1, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, PPARA, SRC |
3.75537 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, IDO1, MAOB, XDH |
3.71184 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.62146 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC, THRA |
3.50221 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.46039 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2, XDH |
3.24345 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.19925 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC, THRA |
3.10559 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DHFR, FLT3, GSK3B, HSD17B1, IDO1, IGF1R, KDR, MAOB, MET, MMP12, NR1H4, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, THRA, THRB, XDH |
2.85917 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.64984 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.61323 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.57959 |
[MF] GO:0004938 |
None
|
ADRA2A, ADRA2C |
2.57959 |
[MF] GO:1901338 |
None
|
ADRA2A, ADRA2C, DRD1 |
2.5338 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2 |
2.47804 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
2.47579 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CSNK2A1, DAO, DHFR, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IGF1R, KDR, MAOB, MET, NR1H4, PDE5A, PIM1, SRC, XDH |
2.43756 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.34813 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.34813 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.34813 |
[MF] GO:0043168 |
anion binding
|
APP, AURKB, AXL, CSNK2A1, DAO, DHFR, F3, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IGF1R, KDR, MAOB, MET, NR1H4, PDE5A, PIM1, SRC, XDH |
2.29852 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.25749 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX5, IDO1, PTGS2 |
2.21308 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.16938 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AR, AURKB, CDC25B, CYP1A1, CYP1A2, CYP3A4, F3, GSK3B, MET, NR3C1, PGR, PPARA, PTGS2, PTPN1, SRC, THRB |
2.11367 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.07836 |
[MF] GO:0051879 |
Hsp90 protein binding
|
CSNK2A1, KDR, NR3C1 |
2.04961 |
[MF] GO:0004936 |
None
|
ADRA2A, ADRA2C |
2.04355 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.04355 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, ADRA2C, APP, CSNK2A1, FLT3, IGF1R, KDR, MAOB, MET, MMP9, PGR, PTGS2, TYR, XDH |
2.04009 |